Aqua Bio Technology Balance Sheet Health
Financial Health criteria checks 0/6
Aqua Bio Technology has a total shareholder equity of NOK7.7M and total debt of NOK20.3M, which brings its debt-to-equity ratio to 264.7%. Its total assets and total liabilities are NOK66.7M and NOK59.0M respectively.
Key information
264.7%
Debt to equity ratio
NOK 20.33m
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 727.44k |
| Equity | NOK 7.68m |
| Total liabilities | NOK 58.99m |
| Total assets | NOK 66.67m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: ABTEC's short term assets (NOK11.1M) do not cover its short term liabilities (NOK33.6M).
Long Term Liabilities: ABTEC's short term assets (NOK11.1M) do not cover its long term liabilities (NOK25.4M).
Debt to Equity History and Analysis
Debt Level: ABTEC's net debt to equity ratio (255.2%) is considered high.
Reducing Debt: ABTEC's debt to equity ratio has increased from 1.7% to 264.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ABTEC has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ABTEC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.